Royalty Pharma Acquires Cimzia® and Mircera® Royalties for $124 million

New York, NY – February 29, 2012 - Royalty Pharma announced today that it has acquired certain rights to receive royalties on future worldwide net sales of Cimzia® and Mircera® for an aggregate cash payment of $124 million.

© 2014 Royalty Pharma, RP Management LLC. All Rights Reserved.